• 1.

    Lianage T, et al.. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet 2015; 14:616019.

Buddy Dialysis Probed as Hemodialysis Alternative

Restricted access

More than 2 million individuals die worldwide each year because they don’t have access to renal replacement therapy, a recent Lancet study suggested (1). In many low- and middle-income countries, patients cannot afford or don’t have access to dialysis or transplant, said Peter Kotanko, MD, research director at the Renal Research Institute in New York.

“There is clearly a great unmet need,” Kotanko said. “The main reason why dialysis is not delivered in these areas is because of the high cost.”

Now, mathematical modeling data suggest that it may be possible to use a healthy volunteer’s